Sargent Investment Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $462K | Sell |
1,276
-18
| -1% | -$6.16K | 0.06% | 182 |
|
|
2026
Q1 | $455K | Buy |
1,294
+12
| +0.9% | +$4.28K | 0.06% | 167 |
|
|
2025
Q4 | $420K | Buy |
+1,282
| New | +$407K | 0.05% | 172 |
|
|
2025
Q3 | – | Sell |
-1,330
| Closed | -$379K | – | 128 |
|
|
2025
Q2 | $379K | Buy |
1,330
+118
| +10% | +$33.4K | 0.05% | 178 |
|
|
2025
Q1 | $378K | Sell |
1,212
-31
| -2% | -$9.15K | 0.06% | 172 |
|
|
2024
Q4 | $336K | Buy |
1,243
+189
| +18% | +$56.1K | 0.05% | 174 |
|
|
2024
Q3 | $340K | Buy |
1,054
+10
| +1% | +$3.27K | 0.06% | 153 |
|
|
2024
Q2 | $326K | Buy |
1,044
+14
| +1% | +$4.11K | 0.07% | 155 |
|
|
2024
Q1 | $293K | Buy |
1,030
+16
| +2% | +$4.68K | 0.06% | 162 |
|
|
2023
Q4 | $292K | Sell |
1,014
-284
| -22% | -$77.4K | 0.06% | 169 |
|
|
2023
Q3 | $349K | Buy |
1,298
+15
| +1% | +$3.74K | 0.08% | 144 |
|
|
2023
Q2 | $285K | Buy |
1,283
+3
| +0.2% | +$696 | 0.07% | 155 |
|
|
2023
Q1 | $313K | Buy |
1,280
+15
| +1% | +$3.68K | 0.08% | 147 |
|
|
2022
Q4 | $332K | Buy |
1,265
+300
| +31% | +$80.4K | 0.1% | 134 |
|
|
2022
Q3 | $223K | Hold |
965
| – | – | 0.07% | 159 |
|
|
2022
Q2 | $235K | Hold |
965
| – | – | 0.07% | 154 |
|
|
2022
Q1 | $233K | Sell |
965
-29
| -3% | -$6.66K | 0.06% | 168 |
|
|
2021
Q4 | $224K | Buy |
994
+30
| +3% | +$6.33K | 0.05% | 167 |
|
|
2021
Q3 | $205K | Sell |
964
-56
| -5% | -$12.9K | 0.05% | 177 |
|
|
2021
Q2 | $249K | Buy |
1,020
+170
| +20% | +$41.8K | 0.06% | 173 |
|
|
2021
Q1 | $211K | Buy |
+850
| New | +$203K | 0.06% | 179 |
|
|
2020
Q4 | – | Sell |
-850
| Closed | -$216K | – | 189 |
|
|
2020
Q3 | $216K | Hold |
850
| – | – | 0.08% | 148 |
|
|
2020
Q2 | $217K | Buy |
+850
| New | +$194K | 0.08% | 138 |
|
|
2020
Q1 | – | Sell |
-850
| Closed | -$205K | – | 137 |
|
|
2019
Q4 | $205K | Buy |
+850
| New | +$187K | 0.08% | 141 |
|
|
2019
Q3 | – | Sell |
-2,000
| Closed | -$369K | – | 139 |
|
|
2019
Q2 | $369K | Hold |
2,000
| – | – | 0.17% | 97 |
|
|
2019
Q1 | $380K | Hold |
2,000
| – | – | 0.18% | 95 |
|
|
2018
Q4 | $389K | Buy |
+2,000
| New | +$390K | 0.24% | 79 |
|
Other funds holding AMGN
Sargent Investment Group's AMGN Position: Q2 2026 in Review
Sargent Investment Group reduced its Amgen (AMGN) stake by 1.4% in Q2 2026, selling an estimated $6.16K and leaving 1,276 shares worth $462K. The position accounts for 0.06% of the portfolio, ranked #182.
Sargent Investment Group first reported a position in AMGN in Q4 2018 and has held it in 27 quarters since. 3,158 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Sargent Investment Group held 1,276 shares of Amgen worth $462K as of Q2 2026.
- Sargent Investment Group sold 18 Amgen shares in Q2 2026, an estimated $6.16K.
- Amgen made up 0.06% of Sargent Investment Group's portfolio in Q2 2026, its #182 holding.
- Sargent Investment Group first reported a position in Amgen in Q4 2018 and has held it in 27 quarters since.
- 3,158 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Sargent Investment Group's 13F filing for Q2 2026, filed 11 Aug 2026.